Abstract: The present invention provides a light emitting device 11 that includes a support substrate 13, partition walls 12 provided on the support substrate 13 and defining sections set on the support substrate 13, and a plurality of organic electroluminescent (EL) elements 14 provided on the sections defined by the partition walls 12. Each of the organic EL elements 14 is configured by laminating a first electrode 15, an organic EL layer, and a second electrode 18 in this order on the support substrate 13. At least part of the first electrode 15 is arranged apart from the partition walls 12 on the support substrate 13. The organic EL layer has an extension portion 20 extending from the first electrode 15 to the partition walls 12. A surface of a member in contact with a bottom surface of the extension portion 20 has a lyophilic property higher than that of a surface of each of the partition walls 12.

Abstract: A light-emitting device comprises: a substrate; a plurality of organic electroluminescent elements provided on the substrate; and a partition defining pixel areas in each of which one of the organic EL elements is provided. The partition comprises an insulating film provided with openings each hollowly formed in an area corresponding to one of the pixel areas and a partition body provided on an opposite side of the insulating film with respect to the substrate. Each of the organic EL elements comprises a pair of electrodes and a light-emitting portion that is interposed between the electrodes and that is arranged in an area surrounded by the insulating film. The thickness of the insulating film is smaller than the thickness of the light-emitting portion.

Abstract: This invention relates an .alpha.-glucosidase inhibitor mildly inhibiting .alpha.-glucosidase locally present in the micro-villus of small intestine, a composition principally comprising sugar and containing the inhibitor, a food, a sweetener and a feed. The inhibitor delays the digestion of starch, starch-derived oligosaccharides and sucrose, so that the inhibitor has an action of suppressing rapid increase in blood glucose level and an action of suppressing insulin secretion at a lower level. Thus, the inhibitor is useful for the prophylaxis of obesity and diabetes mellitus. The .alpha.-glucosidase inhibitor of the present invention is composed of nucleotide, nucleoside, or base as the structural component of nucleic acid and one or two or more digestible sugars selected from sucrose, starch and starch-derived oligosaccharide. The .alpha.-glucosidase inhibitor mildly inhibits the action of .alpha.